Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study.

BMC Public Health
Elizabeth C RussellKatherine L Fielding

Abstract

Antiretroviral therapy (ART) has dramatically reduced morbidity and mortality among people with HIV infection; however, mortality after the start of ART is high in resource-limited settings. We investigated risk factors for mortality among adults starting ART in a multi-clinic community programme in South Africa. Cohort of adults starting ART at 27 clinics between February 2005 and June 2006, followed to 31st March 2007. Kaplan-Meier survival estimates were used to describe overall mortality. Shared frailty Cox regression was used to identify baseline risk factors for early mortality. Among 1350 participants (median age 35.5 years, 60% female, median CD4 count 83/microL [interquartile range (27-147)], median follow-up 13.4 months), there were 185 deaths, overall mortality rate 13/100 pyrs; for 0-3, 3-9 and >9 months from ART start mortality rates were 24, 13 and 6/100 pyrs respectively. 43% of the deaths were in the first 3 months of treatment. Risk factors for mortality in univariable analysis were baseline CD4 count, viral load, haemoglobin and body mass index, in multivariable analysis adjusting for age and gender, only CD4 count and haemoglobin remained independently associated with proportional hazards not being satisfied ...Continue Reading

References

Oct 27, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·C William WesterRichard Marlink
Aug 15, 2006·JAMA : the Journal of the American Medical Association·Jeffrey S A StringerMoses Sinkala
Nov 30, 2006·AIDS Care·S CharalambousG J Churchyard
Nov 1, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Rishikesh P DalalWillem D F Venter
Nov 18, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·Peter MacPhersonPaul Pronyk

❮ Previous
Next ❯

Citations

Jun 5, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Mark J GigantiBenjamin H Chi
Dec 10, 2013·Hematology·Amanda J Redig, Nancy Berliner
Jul 13, 2011·BMC Infectious Diseases·Asgeir JohannessenJohan N Bruun
Sep 14, 2012·PLoS Medicine·Morna CornellUNKNOWN International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration
Aug 21, 2012·PloS One·Trinh DuongUNKNOWN Program for HIV Prevention and Treatment Study Group
Aug 8, 2013·Statistics in Medicine·Tim P MorrisAngela M Wood
Jun 23, 2015·Statistics in Medicine·Tim P MorrisPatrick Royston
Apr 2, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rupak ShivakotiUNKNOWN New Work Concept Sheet 319 and The Prospective Evaluation of Antiretrovirals in Resource-Limited Settings Study Team
Dec 9, 2016·The American Journal of Tropical Medicine and Hygiene·Yukari C ManabeFrank Cobelens
Oct 7, 2011·The Cochrane Database of Systematic Reviews·Arturo J Martí-CarvajalGabriella Comunián-Carrasco

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.